Direxion Daily S&P Biotech Bull 3X Shares Price & Performance (LABU)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) has seen its price fall to $46.10 as of April 21, marking a 4.24% decline from the previous week. With a one-year loss exceeding 46%, the fund continues to exhibit high volatility, underscoring the risks of leveraged biotech exposure.12

Direxion Daily S&P Biotech Bull 3X Shares (LABU) closed at $47.00, down nearly 49% over the last year. Despite a recent dividend payout, the ETF's high beta and sharp price swings highlight persistent instability in the biotech sector, challenging bullish investors seeking leveraged returns.32

LABU's current price stands at $47, far from its 52-week high of $152.60. Historical performance data show the ETF has declined in two-thirds of the past nine years, and analysts currently rate it as a 'Sell,' reflecting continued skepticism about its near-term prospects.34